The consortium leader, i.e. the Institute of Bioorganic Chemistry of the Polish Academy of Sciences, including the Poznań Supercomputing and Networking Center, will cooperate with the following eleven research units:
- Institute of Human Genetics, Polish Academy of Sciences
- Nencki Institute of Experimental Biology, Polish Academy of Sciences
- Poznan University of technology
- University of Warsaw
- Medical University of Bialystok
- University of Lodz
- University of Gdańsk
- Jagiellonian University
- The Cardinal Stefan Wyszyński Institute of Cardiology – National Research Institute in Warsaw
- Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO) | Gliwice
- Łukasiewicz Research Network - PORT Polish Center for Technology Development.
The primary goal of the project is to create a nationwide network of laboratories conducting research and offering services in the field of genomics for scientific, commercial and healthcare institutions. These activities will support the development of science, personalised medicine, precise diagnostics, innovative therapies and targeted prevention.
The network will be equipped with modern genome research infrastructure, including long-read high-throughput sequencing machines and an optical mapping device. The project will also result in the gathering of new genome collections, including those from patients with rare diseases, the integration and re-analysis of existing data and their sharing within a nationwide repository. New IT tools for genome analysis will also be developed, utilising artificial intelligence algorithms and quantum technologies.
Population genomic research contributes to a deeper understanding of genetic variation, disease prevalence and predisposition, enabling improved diagnostics, personalised treatment, as well as more effective preventive measures. It also translates into tangible economic benefits, since well-targeted prevention, precise diagnostics and personalised therapy reduce healthcare costs. The project plans to sequence samples from 6,000-7,000 donors. Some of these samples will constitute Poland's contribution to the European Genome of Europe (GoE) project.
Project value: PLN 248,337,770.24.
Funding amount: PLN 180,481,656.59.
Implementation period: 2026-2029.
In-kind contributions to the project are provided by BCODERS S.A. and Analityk Genetyka Unrug Wójtowicz Sp. k.
The project is co-financed by the European Union under the European Funds for Modern Economy programme.
Informacje: dr hab. Agnieszka Grzelak (Centre for Digital Biology and Biomedical Sciences – Biobank Łódź, Faculty of Biology and Environmental Protection, University of Lodz)
Edit: Mateusz Kowalski (Faculty of Biology and Environmental Protection, University of Lodz)
